Clinical Trial Update: Safety and Efficacy of MT-4666 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of MT-4666 for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• MT-4666

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED